A potentially more effective treatment for HER2 mutant metastatic breast cancer
A phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.
Read moreA phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.
Read moreThe bone microenvironment prompts changes in breast cancer cells that help them escape treatment and become more invasive.
Read moreCancer metastasis is all about rogue cancer cells abandoning the original tumor and venturing through the blood in search for new breeding grounds. Sometimes, single
Read moreImagine fighting enemies that differ in their susceptibility to the weapon you are using against them. Some will perish, but others will survive the attack
Read moreUnraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And
Read moreResistance to therapy is common in estrogen receptor positive (ER+) breast cancer, the most common type of breast cancer, and eventual development of metastatic disease
Read moreTo generate energy from glucose, cells can use one of two pathways. One of them takes place in the mitochondria, energy-producing structures inside cells, and
Read moreThe prognosis of a cancer patient relies significantly on the ability of the surgeon to remove all the tumor, including a cancer-free boundary, leaving what
Read moreFor many cancer patients, the problem is metastasis – the dissemination of tumor cells to other organs – after the primary tumor has been eliminated.
Read moreDespite the overall success of hormone therapy, breast cancer tumors in patients with metastatic disease often fail to respond. One new mechanism that can explain
Read more